Nuvectis Pharma's total assets for Q4 2023 were $19.18M, a decrease of -13.82% from the previous quarter. NVCT total liabilities were $6.98M for the fiscal quarter, a 25.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.